Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
6,982
archived clinical trials in
Endocrine

A Novel Diet-Phenotype Interaction Affecting Body Weight
A Novel Diet-Phenotype Interaction Affecting Body Weight
Status: Enrolling
Updated:  2/8/2016
University of North Carolina at Chapel Hill
344
mi
from 43215
Chapel Hill, NC
A Novel Diet-Phenotype Interaction Affecting Body Weight
A Novel Diet-Phenotype Interaction Affecting Body Weight
Status: Enrolling
Updated: 2/8/2016
University of North Carolina at Chapel Hill
344
mi
from 43215
Chapel Hill, NC
Click here to add this to my saved trials
A Novel Diet-Phenotype Interaction Affecting Body Weight
A Novel Diet-Phenotype Interaction Affecting Body Weight
Status: Enrolling
Updated:  2/8/2016
Children's Hospital Boston
641
mi
from 43215
Boston, MA
A Novel Diet-Phenotype Interaction Affecting Body Weight
A Novel Diet-Phenotype Interaction Affecting Body Weight
Status: Enrolling
Updated: 2/8/2016
Children's Hospital Boston
641
mi
from 43215
Boston, MA
Click here to add this to my saved trials
One Week Parathyroid Hormone-related Protein (PTHrP) IV Dose Escalation Study
Determining the Maximal Safe Dose of a Continuous Infusion of Parathyroid Hormone-related Protein(1-36): Effects on Bone Formation
Status: Enrolling
Updated:  2/9/2016
University of Pittsburgh Medical Center
165
mi
from 43215
Pittsburgh, PA
One Week Parathyroid Hormone-related Protein (PTHrP) IV Dose Escalation Study
Determining the Maximal Safe Dose of a Continuous Infusion of Parathyroid Hormone-related Protein(1-36): Effects on Bone Formation
Status: Enrolling
Updated: 2/9/2016
University of Pittsburgh Medical Center
165
mi
from 43215
Pittsburgh, PA
Click here to add this to my saved trials
Twenty-four Hour Intraocular Pressure Patterns in Patients With Uncontrolled Thyroid Eye Disease
The Effects of Orbital Decompression Surgery on Intraocular Pressure Patterns in Patient With Thyroid Eye Disease Undergoing 24 Hour Continuous IOP Monitoring With the SENSIMED Triggerfish®
Status: Enrolling
Updated:  2/15/2016
Shiley Eye Center, University of California, San Diego
1950
mi
from 43215
La Jolla, CA
Twenty-four Hour Intraocular Pressure Patterns in Patients With Uncontrolled Thyroid Eye Disease
The Effects of Orbital Decompression Surgery on Intraocular Pressure Patterns in Patient With Thyroid Eye Disease Undergoing 24 Hour Continuous IOP Monitoring With the SENSIMED Triggerfish®
Status: Enrolling
Updated: 2/15/2016
Shiley Eye Center, University of California, San Diego
1950
mi
from 43215
La Jolla, CA
Click here to add this to my saved trials
Effect of Naltrexone on Counterregulatory Mechanisms in Hypoglycemia
The Effect of Opiate Blockade With Naltrexone on Counterregulatory Mechanisms in Hypoglycemia
Status: Enrolling
Updated:  2/17/2016
Yale School of Medicine
537
mi
from 43215
New Haven, CT
Effect of Naltrexone on Counterregulatory Mechanisms in Hypoglycemia
The Effect of Opiate Blockade With Naltrexone on Counterregulatory Mechanisms in Hypoglycemia
Status: Enrolling
Updated: 2/17/2016
Yale School of Medicine
537
mi
from 43215
New Haven, CT
Click here to add this to my saved trials
Effect of Age on Glucose and Lipid Metabolism
Effect of Age on Glucose and Lipid Metabolism
Status: Enrolling
Updated:  2/17/2016
Texas Diabetes Insitute
1135
mi
from 43215
San Antonio, TX
Effect of Age on Glucose and Lipid Metabolism
Effect of Age on Glucose and Lipid Metabolism
Status: Enrolling
Updated: 2/17/2016
Texas Diabetes Insitute
1135
mi
from 43215
San Antonio, TX
Click here to add this to my saved trials
Comparison of Endobronchial Ultrasound-Guided Biopsy Using Fine Needle Aspiration Versus Fine Needle Capillary Sampling
Specimen Adequacy and Diagnostic Agreement of Fine Needle Aspiration (FNA) VS. Fine Needle Capillary Sampling (FNC) of Endobronchial Ultrasound-Guided Biopsy of Mediastinal Lymph Nodes
Status: Enrolling
Updated:  2/17/2016
UT MD Anderson Cancer Center
995
mi
from 43215
Houston, TX
Comparison of Endobronchial Ultrasound-Guided Biopsy Using Fine Needle Aspiration Versus Fine Needle Capillary Sampling
Specimen Adequacy and Diagnostic Agreement of Fine Needle Aspiration (FNA) VS. Fine Needle Capillary Sampling (FNC) of Endobronchial Ultrasound-Guided Biopsy of Mediastinal Lymph Nodes
Status: Enrolling
Updated: 2/17/2016
UT MD Anderson Cancer Center
995
mi
from 43215
Houston, TX
Click here to add this to my saved trials
Trial of LBH589 in Metastatic Thyroid Cancer
A Phase II Trial of LBH589 in Patients With Metastatic Medullary Thyroid Cancer and Radioactive Iodine Resistant Differentiated Thyroid Cancer
Status: Enrolling
Updated:  2/18/2016
St Vincent Regional Cancer Center CCOP
403
mi
from 43215
Green Bay, WI
Trial of LBH589 in Metastatic Thyroid Cancer
A Phase II Trial of LBH589 in Patients With Metastatic Medullary Thyroid Cancer and Radioactive Iodine Resistant Differentiated Thyroid Cancer
Status: Enrolling
Updated: 2/18/2016
St Vincent Regional Cancer Center CCOP
403
mi
from 43215
Green Bay, WI
Click here to add this to my saved trials
Trial of LBH589 in Metastatic Thyroid Cancer
A Phase II Trial of LBH589 in Patients With Metastatic Medullary Thyroid Cancer and Radioactive Iodine Resistant Differentiated Thyroid Cancer
Status: Enrolling
Updated:  2/18/2016
University of Wisconsin-Madison
394
mi
from 43215
Madison, WI
Trial of LBH589 in Metastatic Thyroid Cancer
A Phase II Trial of LBH589 in Patients With Metastatic Medullary Thyroid Cancer and Radioactive Iodine Resistant Differentiated Thyroid Cancer
Status: Enrolling
Updated: 2/18/2016
University of Wisconsin-Madison
394
mi
from 43215
Madison, WI
Click here to add this to my saved trials
Trial of LBH589 in Metastatic Thyroid Cancer
A Phase II Trial of LBH589 in Patients With Metastatic Medullary Thyroid Cancer and Radioactive Iodine Resistant Differentiated Thyroid Cancer
Status: Enrolling
Updated:  2/18/2016
Medical College of Wisconsin
330
mi
from 43215
Milwaukee, WI
Trial of LBH589 in Metastatic Thyroid Cancer
A Phase II Trial of LBH589 in Patients With Metastatic Medullary Thyroid Cancer and Radioactive Iodine Resistant Differentiated Thyroid Cancer
Status: Enrolling
Updated: 2/18/2016
Medical College of Wisconsin
330
mi
from 43215
Milwaukee, WI
Click here to add this to my saved trials
Ponatinib for Advanced Medullary Thyroid Cancer
A Phase II Study of Ponatinib in Advanced or Metastatic Medullary Thyroid Cancer
Status: Enrolling
Updated:  2/18/2016
National Institutes of Health Clinical Center, 9000 Rockville Pike
322
mi
from 43215
Bethesda, MD
Ponatinib for Advanced Medullary Thyroid Cancer
A Phase II Study of Ponatinib in Advanced or Metastatic Medullary Thyroid Cancer
Status: Enrolling
Updated: 2/18/2016
National Institutes of Health Clinical Center, 9000 Rockville Pike
322
mi
from 43215
Bethesda, MD
Click here to add this to my saved trials
Metabolic Effects of Androgenicity in Aging Men and Women
Metabolic Effects of Androgenicity in Aging Men and Women
Status: Enrolling
Updated:  2/19/2016
VA Greater Los Angeles Healthcare System, West LA
1982
mi
from 43215
West Los Angeles, CA
Metabolic Effects of Androgenicity in Aging Men and Women
Metabolic Effects of Androgenicity in Aging Men and Women
Status: Enrolling
Updated: 2/19/2016
VA Greater Los Angeles Healthcare System, West LA
1982
mi
from 43215
West Los Angeles, CA
Click here to add this to my saved trials
Diet, Exercise, Niacin, and Fenofibrate to Reduce Heart Disease Risk Factors in Individuals With HIV Lipodystrophy or Dyslipidemia
Diet/Exercise, Niacin, Fenofibrate for HIV Lipodystrophy
Status: Enrolling
Updated:  2/25/2016
Baylor College of Medicine
991
mi
from 43215
Houston, TX
Diet, Exercise, Niacin, and Fenofibrate to Reduce Heart Disease Risk Factors in Individuals With HIV Lipodystrophy or Dyslipidemia
Diet/Exercise, Niacin, Fenofibrate for HIV Lipodystrophy
Status: Enrolling
Updated: 2/25/2016
Baylor College of Medicine
991
mi
from 43215
Houston, TX
Click here to add this to my saved trials
Effect of Formoterol on the Counterregulatory Hormonal Response to Hypoglycemia in Type 1 Diabetes.
The Effect of the Beta 2 Agonist, Formoterol, on Recovery From Hypoglycemia
Status: Enrolling
Updated:  2/26/2016
Yale University School of Medicine
537
mi
from 43215
New Haven, CT
Effect of Formoterol on the Counterregulatory Hormonal Response to Hypoglycemia in Type 1 Diabetes.
The Effect of the Beta 2 Agonist, Formoterol, on Recovery From Hypoglycemia
Status: Enrolling
Updated: 2/26/2016
Yale University School of Medicine
537
mi
from 43215
New Haven, CT
Click here to add this to my saved trials
Comparison of Two Forms of Hydrocortisone in Patients With Congenital Adrenal Hyperplasia
A Phase 2, Open Label, Crossover Pharmacokinetic and Pharmacodynamic Study to Compare Chronocort Versus Cortef in Patients With CAH
Status: Enrolling
Updated:  2/26/2016
National Institutes of Health Clinical Center, 9000 Rockville Pike
322
mi
from 43215
Bethesda, MD
Comparison of Two Forms of Hydrocortisone in Patients With Congenital Adrenal Hyperplasia
A Phase 2, Open Label, Crossover Pharmacokinetic and Pharmacodynamic Study to Compare Chronocort Versus Cortef in Patients With CAH
Status: Enrolling
Updated: 2/26/2016
National Institutes of Health Clinical Center, 9000 Rockville Pike
322
mi
from 43215
Bethesda, MD
Click here to add this to my saved trials
Metabolic Abnormalities in HIV Infected and Uninfected Young Women
Prevalence of Morphologic and Metabolic Abnormalities in HIV Infected and Uninfected Young Women
Status: Enrolling
Updated:  2/29/2016
Children's Hopsital of Los Angeles
1973
mi
from 43215
Los Angeles, CA
Metabolic Abnormalities in HIV Infected and Uninfected Young Women
Prevalence of Morphologic and Metabolic Abnormalities in HIV Infected and Uninfected Young Women
Status: Enrolling
Updated: 2/29/2016
Children's Hopsital of Los Angeles
1973
mi
from 43215
Los Angeles, CA
Click here to add this to my saved trials
Metabolic Abnormalities in HIV Infected and Uninfected Young Women
Prevalence of Morphologic and Metabolic Abnormalities in HIV Infected and Uninfected Young Women
Status: Enrolling
Updated:  2/29/2016
University of California, San Diego
1926
mi
from 43215
San Diego, CA
Metabolic Abnormalities in HIV Infected and Uninfected Young Women
Prevalence of Morphologic and Metabolic Abnormalities in HIV Infected and Uninfected Young Women
Status: Enrolling
Updated: 2/29/2016
University of California, San Diego
1926
mi
from 43215
San Diego, CA
Click here to add this to my saved trials
Metabolic Abnormalities in HIV Infected and Uninfected Young Women
Prevalence of Morphologic and Metabolic Abnormalities in HIV Infected and Uninfected Young Women
Status: Enrolling
Updated:  2/29/2016
Childrens National Medical Center
328
mi
from 43215
Washington,
Metabolic Abnormalities in HIV Infected and Uninfected Young Women
Prevalence of Morphologic and Metabolic Abnormalities in HIV Infected and Uninfected Young Women
Status: Enrolling
Updated: 2/29/2016
Childrens National Medical Center
328
mi
from 43215
Washington,
Click here to add this to my saved trials
Metabolic Abnormalities in HIV Infected and Uninfected Young Women
Prevalence of Morphologic and Metabolic Abnormalities in HIV Infected and Uninfected Young Women
Status: Enrolling
Updated:  2/29/2016
Children'S Diagnostic Treatment Center
971
mi
from 43215
Fort Lauderdale, FL
Metabolic Abnormalities in HIV Infected and Uninfected Young Women
Prevalence of Morphologic and Metabolic Abnormalities in HIV Infected and Uninfected Young Women
Status: Enrolling
Updated: 2/29/2016
Children'S Diagnostic Treatment Center
971
mi
from 43215
Fort Lauderdale, FL
Click here to add this to my saved trials
Metabolic Abnormalities in HIV Infected and Uninfected Young Women
Prevalence of Morphologic and Metabolic Abnormalities in HIV Infected and Uninfected Young Women
Status: Enrolling
Updated:  2/29/2016
University of Miami
992
mi
from 43215
Miami, FL
Metabolic Abnormalities in HIV Infected and Uninfected Young Women
Prevalence of Morphologic and Metabolic Abnormalities in HIV Infected and Uninfected Young Women
Status: Enrolling
Updated: 2/29/2016
University of Miami
992
mi
from 43215
Miami, FL
Click here to add this to my saved trials
Metabolic Abnormalities in HIV Infected and Uninfected Young Women
Prevalence of Morphologic and Metabolic Abnormalities in HIV Infected and Uninfected Young Women
Status: Enrolling
Updated:  2/29/2016
University of South Florida
822
mi
from 43215
Tampa, FL
Metabolic Abnormalities in HIV Infected and Uninfected Young Women
Prevalence of Morphologic and Metabolic Abnormalities in HIV Infected and Uninfected Young Women
Status: Enrolling
Updated: 2/29/2016
University of South Florida
822
mi
from 43215
Tampa, FL
Click here to add this to my saved trials
Metabolic Abnormalities in HIV Infected and Uninfected Young Women
Prevalence of Morphologic and Metabolic Abnormalities in HIV Infected and Uninfected Young Women
Status: Enrolling
Updated:  2/29/2016
Stoger Hospital of Cook County
274
mi
from 43215
Chicago, IL
Metabolic Abnormalities in HIV Infected and Uninfected Young Women
Prevalence of Morphologic and Metabolic Abnormalities in HIV Infected and Uninfected Young Women
Status: Enrolling
Updated: 2/29/2016
Stoger Hospital of Cook County
274
mi
from 43215
Chicago, IL
Click here to add this to my saved trials
Metabolic Abnormalities in HIV Infected and Uninfected Young Women
Prevalence of Morphologic and Metabolic Abnormalities in HIV Infected and Uninfected Young Women
Status: Enrolling
Updated:  2/29/2016
Tulane University
797
mi
from 43215
New Orleans, LA
Metabolic Abnormalities in HIV Infected and Uninfected Young Women
Prevalence of Morphologic and Metabolic Abnormalities in HIV Infected and Uninfected Young Women
Status: Enrolling
Updated: 2/29/2016
Tulane University
797
mi
from 43215
New Orleans, LA
Click here to add this to my saved trials
Metabolic Abnormalities in HIV Infected and Uninfected Young Women
Prevalence of Morphologic and Metabolic Abnormalities in HIV Infected and Uninfected Young Women
Status: Enrolling
Updated:  2/29/2016
Montefiore Medical Center
484
mi
from 43215
Bronx, NY
Metabolic Abnormalities in HIV Infected and Uninfected Young Women
Prevalence of Morphologic and Metabolic Abnormalities in HIV Infected and Uninfected Young Women
Status: Enrolling
Updated: 2/29/2016
Montefiore Medical Center
484
mi
from 43215
Bronx, NY
Click here to add this to my saved trials
Metabolic Abnormalities in HIV Infected and Uninfected Young Women
Prevalence of Morphologic and Metabolic Abnormalities in HIV Infected and Uninfected Young Women
Status: Enrolling
Updated:  2/29/2016
Mt. Sinai Hospital
477
mi
from 43215
New York City, NY
Metabolic Abnormalities in HIV Infected and Uninfected Young Women
Prevalence of Morphologic and Metabolic Abnormalities in HIV Infected and Uninfected Young Women
Status: Enrolling
Updated: 2/29/2016
Mt. Sinai Hospital
477
mi
from 43215
New York City, NY
Click here to add this to my saved trials
Metabolic Abnormalities in HIV Infected and Uninfected Young Women
Prevalence of Morphologic and Metabolic Abnormalities in HIV Infected and Uninfected Young Women
Status: Enrolling
Updated:  2/29/2016
Children's Hospital of Philadelphia
416
mi
from 43215
Philadelphia, PA
Metabolic Abnormalities in HIV Infected and Uninfected Young Women
Prevalence of Morphologic and Metabolic Abnormalities in HIV Infected and Uninfected Young Women
Status: Enrolling
Updated: 2/29/2016
Children's Hospital of Philadelphia
416
mi
from 43215
Philadelphia, PA
Click here to add this to my saved trials
Identification of Celiac Ganglia
Identification of Celiac Ganglia for Endoscopic Ultrasound
Status: Enrolling
Updated:  2/29/2016
Indiana University
167
mi
from 43215
Indianapolis, IN
Identification of Celiac Ganglia
Identification of Celiac Ganglia for Endoscopic Ultrasound
Status: Enrolling
Updated: 2/29/2016
Indiana University
167
mi
from 43215
Indianapolis, IN
Click here to add this to my saved trials
Progressive Weight Loss and Metabolic Health
Progressive Weight Loss and Metabolic Health
Status: Enrolling
Updated:  3/1/2016
Washington University School of Medicine
397
mi
from 43215
Saint Louis, MO
Progressive Weight Loss and Metabolic Health
Progressive Weight Loss and Metabolic Health
Status: Enrolling
Updated: 3/1/2016
Washington University School of Medicine
397
mi
from 43215
Saint Louis, MO
Click here to add this to my saved trials
Ghrelin and Insulin Resistance
Role of Ghrelin in the Improvement of Insulin Resistance After Roux-en-Y Gastric Bypass Surgery
Status: Enrolling
Updated:  3/2/2016
Vanderbilt University Medical Center
333
mi
from 43215
Nashville, TN
Ghrelin and Insulin Resistance
Role of Ghrelin in the Improvement of Insulin Resistance After Roux-en-Y Gastric Bypass Surgery
Status: Enrolling
Updated: 3/2/2016
Vanderbilt University Medical Center
333
mi
from 43215
Nashville, TN
Click here to add this to my saved trials
Study to Assess Safety and Tolerability in Adults With Growth Hormone-Deficiency (GHD)
A Phase 3, Multicenter, Randomized, Open-Label, Comparator-Controlled Study to Assess Safety and Tolerability of Weekly TV-1106 Compared to Daily rhGH (dGH) in Adults With Growth Hormone-Deficiency
Status: Enrolling
Updated:  3/2/2016
Teva Investigational Site 13102
1968
mi
from 43215
Artesia, CA
Study to Assess Safety and Tolerability in Adults With Growth Hormone-Deficiency (GHD)
A Phase 3, Multicenter, Randomized, Open-Label, Comparator-Controlled Study to Assess Safety and Tolerability of Weekly TV-1106 Compared to Daily rhGH (dGH) in Adults With Growth Hormone-Deficiency
Status: Enrolling
Updated: 3/2/2016
Teva Investigational Site 13102
1968
mi
from 43215
Artesia, CA
Click here to add this to my saved trials
Study to Assess Safety and Tolerability in Adults With Growth Hormone-Deficiency (GHD)
A Phase 3, Multicenter, Randomized, Open-Label, Comparator-Controlled Study to Assess Safety and Tolerability of Weekly TV-1106 Compared to Daily rhGH (dGH) in Adults With Growth Hormone-Deficiency
Status: Enrolling
Updated:  3/2/2016
Teva Investigational Site 15
1965
mi
from 43215
Fountain Valley, CA
Study to Assess Safety and Tolerability in Adults With Growth Hormone-Deficiency (GHD)
A Phase 3, Multicenter, Randomized, Open-Label, Comparator-Controlled Study to Assess Safety and Tolerability of Weekly TV-1106 Compared to Daily rhGH (dGH) in Adults With Growth Hormone-Deficiency
Status: Enrolling
Updated: 3/2/2016
Teva Investigational Site 15
1965
mi
from 43215
Fountain Valley, CA
Click here to add this to my saved trials
Study to Assess Safety and Tolerability in Adults With Growth Hormone-Deficiency (GHD)
A Phase 3, Multicenter, Randomized, Open-Label, Comparator-Controlled Study to Assess Safety and Tolerability of Weekly TV-1106 Compared to Daily rhGH (dGH) in Adults With Growth Hormone-Deficiency
Status: Enrolling
Updated:  3/2/2016
Teva Investigational Site 13165
1971
mi
from 43215
Lakewood, CA
Study to Assess Safety and Tolerability in Adults With Growth Hormone-Deficiency (GHD)
A Phase 3, Multicenter, Randomized, Open-Label, Comparator-Controlled Study to Assess Safety and Tolerability of Weekly TV-1106 Compared to Daily rhGH (dGH) in Adults With Growth Hormone-Deficiency
Status: Enrolling
Updated: 3/2/2016
Teva Investigational Site 13165
1971
mi
from 43215
Lakewood, CA
Click here to add this to my saved trials
Study to Assess Safety and Tolerability in Adults With Growth Hormone-Deficiency (GHD)
A Phase 3, Multicenter, Randomized, Open-Label, Comparator-Controlled Study to Assess Safety and Tolerability of Weekly TV-1106 Compared to Daily rhGH (dGH) in Adults With Growth Hormone-Deficiency
Status: Enrolling
Updated:  3/2/2016
Teva Investigational Site 10133
1162
mi
from 43215
Denver, CO
Study to Assess Safety and Tolerability in Adults With Growth Hormone-Deficiency (GHD)
A Phase 3, Multicenter, Randomized, Open-Label, Comparator-Controlled Study to Assess Safety and Tolerability of Weekly TV-1106 Compared to Daily rhGH (dGH) in Adults With Growth Hormone-Deficiency
Status: Enrolling
Updated: 3/2/2016
Teva Investigational Site 10133
1162
mi
from 43215
Denver, CO
Click here to add this to my saved trials
Study to Assess Safety and Tolerability in Adults With Growth Hormone-Deficiency (GHD)
A Phase 3, Multicenter, Randomized, Open-Label, Comparator-Controlled Study to Assess Safety and Tolerability of Weekly TV-1106 Compared to Daily rhGH (dGH) in Adults With Growth Hormone-Deficiency
Status: Enrolling
Updated:  3/2/2016
Teva Investigational Site 25
385
mi
from 43215
Newark, DE
Study to Assess Safety and Tolerability in Adults With Growth Hormone-Deficiency (GHD)
A Phase 3, Multicenter, Randomized, Open-Label, Comparator-Controlled Study to Assess Safety and Tolerability of Weekly TV-1106 Compared to Daily rhGH (dGH) in Adults With Growth Hormone-Deficiency
Status: Enrolling
Updated: 3/2/2016
Teva Investigational Site 25
385
mi
from 43215
Newark, DE
Click here to add this to my saved trials
Study to Assess Safety and Tolerability in Adults With Growth Hormone-Deficiency (GHD)
A Phase 3, Multicenter, Randomized, Open-Label, Comparator-Controlled Study to Assess Safety and Tolerability of Weekly TV-1106 Compared to Daily rhGH (dGH) in Adults With Growth Hormone-Deficiency
Status: Enrolling
Updated:  3/2/2016
Teva Investigational Site 12535
978
mi
from 43215
Hollywood, FL
Study to Assess Safety and Tolerability in Adults With Growth Hormone-Deficiency (GHD)
A Phase 3, Multicenter, Randomized, Open-Label, Comparator-Controlled Study to Assess Safety and Tolerability of Weekly TV-1106 Compared to Daily rhGH (dGH) in Adults With Growth Hormone-Deficiency
Status: Enrolling
Updated: 3/2/2016
Teva Investigational Site 12535
978
mi
from 43215
Hollywood, FL
Click here to add this to my saved trials
Study to Assess Safety and Tolerability in Adults With Growth Hormone-Deficiency (GHD)
A Phase 3, Multicenter, Randomized, Open-Label, Comparator-Controlled Study to Assess Safety and Tolerability of Weekly TV-1106 Compared to Daily rhGH (dGH) in Adults With Growth Hormone-Deficiency
Status: Enrolling
Updated:  3/2/2016
Teva Investigational Site 12336
1012
mi
from 43215
Homestead, FL
Study to Assess Safety and Tolerability in Adults With Growth Hormone-Deficiency (GHD)
A Phase 3, Multicenter, Randomized, Open-Label, Comparator-Controlled Study to Assess Safety and Tolerability of Weekly TV-1106 Compared to Daily rhGH (dGH) in Adults With Growth Hormone-Deficiency
Status: Enrolling
Updated: 3/2/2016
Teva Investigational Site 12336
1012
mi
from 43215
Homestead, FL
Click here to add this to my saved trials
Study to Assess Safety and Tolerability in Adults With Growth Hormone-Deficiency (GHD)
A Phase 3, Multicenter, Randomized, Open-Label, Comparator-Controlled Study to Assess Safety and Tolerability of Weekly TV-1106 Compared to Daily rhGH (dGH) in Adults With Growth Hormone-Deficiency
Status: Enrolling
Updated:  3/2/2016
Teva Investigational Site 10247
983
mi
from 43215
Miami Lakes, FL
Study to Assess Safety and Tolerability in Adults With Growth Hormone-Deficiency (GHD)
A Phase 3, Multicenter, Randomized, Open-Label, Comparator-Controlled Study to Assess Safety and Tolerability of Weekly TV-1106 Compared to Daily rhGH (dGH) in Adults With Growth Hormone-Deficiency
Status: Enrolling
Updated: 3/2/2016
Teva Investigational Site 10247
983
mi
from 43215
Miami Lakes, FL
Click here to add this to my saved trials
Study to Assess Safety and Tolerability in Adults With Growth Hormone-Deficiency (GHD)
A Phase 3, Multicenter, Randomized, Open-Label, Comparator-Controlled Study to Assess Safety and Tolerability of Weekly TV-1106 Compared to Daily rhGH (dGH) in Adults With Growth Hormone-Deficiency
Status: Enrolling
Updated:  3/2/2016
Teva Investigational Site 1345
996
mi
from 43215
Miami, FL
Study to Assess Safety and Tolerability in Adults With Growth Hormone-Deficiency (GHD)
A Phase 3, Multicenter, Randomized, Open-Label, Comparator-Controlled Study to Assess Safety and Tolerability of Weekly TV-1106 Compared to Daily rhGH (dGH) in Adults With Growth Hormone-Deficiency
Status: Enrolling
Updated: 3/2/2016
Teva Investigational Site 1345
996
mi
from 43215
Miami, FL
Click here to add this to my saved trials
Study to Assess Safety and Tolerability in Adults With Growth Hormone-Deficiency (GHD)
A Phase 3, Multicenter, Randomized, Open-Label, Comparator-Controlled Study to Assess Safety and Tolerability of Weekly TV-1106 Compared to Daily rhGH (dGH) in Adults With Growth Hormone-Deficiency
Status: Enrolling
Updated:  3/2/2016
Teva Investigational Site 1345
996
mi
from 43215
Miami, FL
Study to Assess Safety and Tolerability in Adults With Growth Hormone-Deficiency (GHD)
A Phase 3, Multicenter, Randomized, Open-Label, Comparator-Controlled Study to Assess Safety and Tolerability of Weekly TV-1106 Compared to Daily rhGH (dGH) in Adults With Growth Hormone-Deficiency
Status: Enrolling
Updated: 3/2/2016
Teva Investigational Site 1345
996
mi
from 43215
Miami, FL
Click here to add this to my saved trials
Study to Assess Safety and Tolerability in Adults With Growth Hormone-Deficiency (GHD)
A Phase 3, Multicenter, Randomized, Open-Label, Comparator-Controlled Study to Assess Safety and Tolerability of Weekly TV-1106 Compared to Daily rhGH (dGH) in Adults With Growth Hormone-Deficiency
Status: Enrolling
Updated:  3/2/2016
Teva Investigational Site 1345
996
mi
from 43215
Miami, FL
Study to Assess Safety and Tolerability in Adults With Growth Hormone-Deficiency (GHD)
A Phase 3, Multicenter, Randomized, Open-Label, Comparator-Controlled Study to Assess Safety and Tolerability of Weekly TV-1106 Compared to Daily rhGH (dGH) in Adults With Growth Hormone-Deficiency
Status: Enrolling
Updated: 3/2/2016
Teva Investigational Site 1345
996
mi
from 43215
Miami, FL
Click here to add this to my saved trials
Study to Assess Safety and Tolerability in Adults With Growth Hormone-Deficiency (GHD)
A Phase 3, Multicenter, Randomized, Open-Label, Comparator-Controlled Study to Assess Safety and Tolerability of Weekly TV-1106 Compared to Daily rhGH (dGH) in Adults With Growth Hormone-Deficiency
Status: Enrolling
Updated:  3/2/2016
Teva Investigational Site 1345
996
mi
from 43215
Miami, FL
Study to Assess Safety and Tolerability in Adults With Growth Hormone-Deficiency (GHD)
A Phase 3, Multicenter, Randomized, Open-Label, Comparator-Controlled Study to Assess Safety and Tolerability of Weekly TV-1106 Compared to Daily rhGH (dGH) in Adults With Growth Hormone-Deficiency
Status: Enrolling
Updated: 3/2/2016
Teva Investigational Site 1345
996
mi
from 43215
Miami, FL
Click here to add this to my saved trials
Study to Assess Safety and Tolerability in Adults With Growth Hormone-Deficiency (GHD)
A Phase 3, Multicenter, Randomized, Open-Label, Comparator-Controlled Study to Assess Safety and Tolerability of Weekly TV-1106 Compared to Daily rhGH (dGH) in Adults With Growth Hormone-Deficiency
Status: Enrolling
Updated:  3/2/2016
Teva Investigational Site 1345
996
mi
from 43215
Miami, FL
Study to Assess Safety and Tolerability in Adults With Growth Hormone-Deficiency (GHD)
A Phase 3, Multicenter, Randomized, Open-Label, Comparator-Controlled Study to Assess Safety and Tolerability of Weekly TV-1106 Compared to Daily rhGH (dGH) in Adults With Growth Hormone-Deficiency
Status: Enrolling
Updated: 3/2/2016
Teva Investigational Site 1345
996
mi
from 43215
Miami, FL
Click here to add this to my saved trials
Study to Assess Safety and Tolerability in Adults With Growth Hormone-Deficiency (GHD)
A Phase 3, Multicenter, Randomized, Open-Label, Comparator-Controlled Study to Assess Safety and Tolerability of Weekly TV-1106 Compared to Daily rhGH (dGH) in Adults With Growth Hormone-Deficiency
Status: Enrolling
Updated:  3/2/2016
Teva Investigational Site ZEIG
976
mi
from 43215
Pembroke Pines, FL
Study to Assess Safety and Tolerability in Adults With Growth Hormone-Deficiency (GHD)
A Phase 3, Multicenter, Randomized, Open-Label, Comparator-Controlled Study to Assess Safety and Tolerability of Weekly TV-1106 Compared to Daily rhGH (dGH) in Adults With Growth Hormone-Deficiency
Status: Enrolling
Updated: 3/2/2016
Teva Investigational Site ZEIG
976
mi
from 43215
Pembroke Pines, FL
Click here to add this to my saved trials
Study to Assess Safety and Tolerability in Adults With Growth Hormone-Deficiency (GHD)
A Phase 3, Multicenter, Randomized, Open-Label, Comparator-Controlled Study to Assess Safety and Tolerability of Weekly TV-1106 Compared to Daily rhGH (dGH) in Adults With Growth Hormone-Deficiency
Status: Enrolling
Updated:  3/2/2016
Teva Investigational Site 13121
931
mi
from 43215
West Palm Beach, FL
Study to Assess Safety and Tolerability in Adults With Growth Hormone-Deficiency (GHD)
A Phase 3, Multicenter, Randomized, Open-Label, Comparator-Controlled Study to Assess Safety and Tolerability of Weekly TV-1106 Compared to Daily rhGH (dGH) in Adults With Growth Hormone-Deficiency
Status: Enrolling
Updated: 3/2/2016
Teva Investigational Site 13121
931
mi
from 43215
West Palm Beach, FL
Click here to add this to my saved trials
Study to Assess Safety and Tolerability in Adults With Growth Hormone-Deficiency (GHD)
A Phase 3, Multicenter, Randomized, Open-Label, Comparator-Controlled Study to Assess Safety and Tolerability of Weekly TV-1106 Compared to Daily rhGH (dGH) in Adults With Growth Hormone-Deficiency
Status: Enrolling
Updated:  3/2/2016
Teva Investigational Site 11
163
mi
from 43215
Detroit, MI
Study to Assess Safety and Tolerability in Adults With Growth Hormone-Deficiency (GHD)
A Phase 3, Multicenter, Randomized, Open-Label, Comparator-Controlled Study to Assess Safety and Tolerability of Weekly TV-1106 Compared to Daily rhGH (dGH) in Adults With Growth Hormone-Deficiency
Status: Enrolling
Updated: 3/2/2016
Teva Investigational Site 11
163
mi
from 43215
Detroit, MI
Click here to add this to my saved trials
Study to Assess Safety and Tolerability in Adults With Growth Hormone-Deficiency (GHD)
A Phase 3, Multicenter, Randomized, Open-Label, Comparator-Controlled Study to Assess Safety and Tolerability of Weekly TV-1106 Compared to Daily rhGH (dGH) in Adults With Growth Hormone-Deficiency
Status: Enrolling
Updated:  3/2/2016
Teva Investigational Site 11136
1751
mi
from 43215
Henderson, NV
Study to Assess Safety and Tolerability in Adults With Growth Hormone-Deficiency (GHD)
A Phase 3, Multicenter, Randomized, Open-Label, Comparator-Controlled Study to Assess Safety and Tolerability of Weekly TV-1106 Compared to Daily rhGH (dGH) in Adults With Growth Hormone-Deficiency
Status: Enrolling
Updated: 3/2/2016
Teva Investigational Site 11136
1751
mi
from 43215
Henderson, NV
Click here to add this to my saved trials
Study to Assess Safety and Tolerability in Adults With Growth Hormone-Deficiency (GHD)
A Phase 3, Multicenter, Randomized, Open-Label, Comparator-Controlled Study to Assess Safety and Tolerability of Weekly TV-1106 Compared to Daily rhGH (dGH) in Adults With Growth Hormone-Deficiency
Status: Enrolling
Updated:  3/2/2016
Teva Investigational Site 60
1756
mi
from 43215
Las Vegas, NV
Study to Assess Safety and Tolerability in Adults With Growth Hormone-Deficiency (GHD)
A Phase 3, Multicenter, Randomized, Open-Label, Comparator-Controlled Study to Assess Safety and Tolerability of Weekly TV-1106 Compared to Daily rhGH (dGH) in Adults With Growth Hormone-Deficiency
Status: Enrolling
Updated: 3/2/2016
Teva Investigational Site 60
1756
mi
from 43215
Las Vegas, NV
Click here to add this to my saved trials
Study to Assess Safety and Tolerability in Adults With Growth Hormone-Deficiency (GHD)
A Phase 3, Multicenter, Randomized, Open-Label, Comparator-Controlled Study to Assess Safety and Tolerability of Weekly TV-1106 Compared to Daily rhGH (dGH) in Adults With Growth Hormone-Deficiency
Status: Enrolling
Updated:  3/2/2016
Teva Investigational Site 10187
480
mi
from 43215
Brooklyn, NY
Study to Assess Safety and Tolerability in Adults With Growth Hormone-Deficiency (GHD)
A Phase 3, Multicenter, Randomized, Open-Label, Comparator-Controlled Study to Assess Safety and Tolerability of Weekly TV-1106 Compared to Daily rhGH (dGH) in Adults With Growth Hormone-Deficiency
Status: Enrolling
Updated: 3/2/2016
Teva Investigational Site 10187
480
mi
from 43215
Brooklyn, NY
Click here to add this to my saved trials
Study to Assess Safety and Tolerability in Adults With Growth Hormone-Deficiency (GHD)
A Phase 3, Multicenter, Randomized, Open-Label, Comparator-Controlled Study to Assess Safety and Tolerability of Weekly TV-1106 Compared to Daily rhGH (dGH) in Adults With Growth Hormone-Deficiency
Status: Enrolling
Updated:  3/2/2016
Teva Investigational Site 1355
477
mi
from 43215
New York, NY
Study to Assess Safety and Tolerability in Adults With Growth Hormone-Deficiency (GHD)
A Phase 3, Multicenter, Randomized, Open-Label, Comparator-Controlled Study to Assess Safety and Tolerability of Weekly TV-1106 Compared to Daily rhGH (dGH) in Adults With Growth Hormone-Deficiency
Status: Enrolling
Updated: 3/2/2016
Teva Investigational Site 1355
477
mi
from 43215
New York, NY
Click here to add this to my saved trials
Study to Assess Safety and Tolerability in Adults With Growth Hormone-Deficiency (GHD)
A Phase 3, Multicenter, Randomized, Open-Label, Comparator-Controlled Study to Assess Safety and Tolerability of Weekly TV-1106 Compared to Daily rhGH (dGH) in Adults With Growth Hormone-Deficiency
Status: Enrolling
Updated:  3/2/2016
Teva Investigational Site 1355
477
mi
from 43215
New York, NY
Study to Assess Safety and Tolerability in Adults With Growth Hormone-Deficiency (GHD)
A Phase 3, Multicenter, Randomized, Open-Label, Comparator-Controlled Study to Assess Safety and Tolerability of Weekly TV-1106 Compared to Daily rhGH (dGH) in Adults With Growth Hormone-Deficiency
Status: Enrolling
Updated: 3/2/2016
Teva Investigational Site 1355
477
mi
from 43215
New York, NY
Click here to add this to my saved trials